The present invention relates to a crystalline form of compound (I), 4-{(1S, 2S)-2-[(4-cyclobutylpiperazin-1-yl)carbonyl]-cyclopropyl}-benzamide,pharmaceutical formulations containing said compound and to the use of said active compound in therapy.本發明係關於化合物(I) 4-{(1S,2S)-2-[(4-環丁基六氫吡嗪-1-基)羰基]-環丙基}-苯甲醯胺之結晶形式、含有該化合物之醫藥調配物及該活性化合物在療法中之用途。(無元件符號說明)